Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.
Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Best foot forward—chemo care should include podiatry, say researchers
2.
Decoding calcifications in breast cancer: Towards personalized medicine
3.
Having a tattoo could increase your risk of developing lymphoma.
4.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
5.
Research team uncovers the underpinnings of head and neck cancers
1.
Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence
2.
Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention
3.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
4.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
5.
Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
4.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation